Artificial Intelligence (AI) in Healthcare Market expected to rise at 40.48% of CAGR by 2027: Triton Market Research
Artificial intelligence in the Healthcare Market is projected to progress at 40.48% of CAGR during the forecasting period 2019-2027.
Introduction to market
The major factors driving the Global AI in the Healthcare Market are the increasing usage of big data, the growing importance of precision medicine, widening applications of AI in genomics and rising need of real-time monitoring systems. Moreover, the positive outlook of healthcare wearable’s industry, rapid growth in robotics and the integration of software with AI are some of the opportunities that are expected to increase the market growth in the coming years. Nevertheless, the lack of standardization of healthcare data and security & privacy issues are top reasons challenging the overall growth of the market across the globe.
Browse full research report with TOC on "Artificial Intelligence in Healthcare Market Analysis By Offerings (Hardware, Services, Software), by Application (Precision Medicine, Robot-Assisted Surgery, Real-Time Monitoring, Diagnostic and Clinical Decision Support, Administrative Workflow Assistance Personal Health and Nursing Assistants, Clinical Trials, Other Application) by Technology (Natural language processing, Context-aware processing, Querying method, Deep learning) by End Users (Pharmaceuticals and biotechnology companies, Patients, ACOS & MCOS, Providers, Payers) and Geography"
Request Free Sample Now: https://www.tritonmarketresearch.com/reports/artificial-intelligence-(ai)-in-healthcare-market#request-free-sample
According to Triton Market research, the North America region held the largest share amongst the various regional markets
North America, Europe, Asia-Pacific and rest of the world are the four regional segments covered in the artificial intelligence in healthcare market. North America leads the global artificial intelligence in healthcare market by holding the largest share. This highest growth of the market is attributed to the high adoption rate of AI, growth, and development of research & development activities coupled with the investments by government and private organizations and rising adoption of machine learning in the medical sector.
The major companies operating in the Alzheimer’s Therapeutics and Diagnostic Market are:
- General Vision Inc.
- GE Healthcare
- Enlitic Inc.
- Deep Genomics Inc.
- Google Inc.
- IBM Corporation
- Next It Corporation
- Intel Corporation
- Microsoft Corporation
- Oncora Medical
- Stryker Corporation
- Recursion Pharmaceuticals, Inc.
- Welltok Inc.
- Nvidia Corporation.
Find more research reports on Lifescience Industry, by Triton Market Research: